68 related articles for article (PubMed ID: 12534800)
1. Fatty acid synthase expression in melanoma.
Innocenzi D; Alò PL; Balzani A; Sebastiani V; Silipo V; La Torre G; Ricciardi G; Bosman C; Calvieri S
J Cutan Pathol; 2003 Jan; 30(1):23-8. PubMed ID: 12534800
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of fatty acid synthase in melanoma cells activates the intrinsic pathway of apoptosis.
Zecchin KG; Rossato FA; Raposo HF; Melo DR; Alberici LC; Oliveira HC; Castilho RF; Coletta RD; Vercesi AE; Graner E
Lab Invest; 2011 Feb; 91(2):232-40. PubMed ID: 20805790
[TBL] [Abstract][Full Text] [Related]
3. The fatty acid synthase inhibitor orlistat reduces the growth and metastasis of orthotopic tongue oral squamous cell carcinomas.
Agostini M; Almeida LY; Bastos DC; Ortega RM; Moreira FS; Seguin F; Zecchin KG; Raposo HF; Oliveira HC; Amoêdo ND; Salo T; Coletta RD; Graner E
Mol Cancer Ther; 2014 Mar; 13(3):585-95. PubMed ID: 24362464
[TBL] [Abstract][Full Text] [Related]
4. Metabolic modelling-based in silico drug target prediction identifies six novel repurposable drugs for melanoma.
Bintener T; Pacheco MP; Philippidou D; Margue C; Kishk A; Del Mistro G; Di Leo L; Moscardó Garcia M; Halder R; Sinkkonen L; De Zio D; Kreis S; Kulms D; Sauter T
Cell Death Dis; 2023 Jul; 14(7):468. PubMed ID: 37495601
[TBL] [Abstract][Full Text] [Related]
5. Involvement of the pro-oncogenic enzyme fatty acid synthase in the hallmarks of cancer: a promising target in anti-cancer therapies.
Vanauberg D; Schulz C; Lefebvre T
Oncogenesis; 2023 Mar; 12(1):16. PubMed ID: 36934087
[TBL] [Abstract][Full Text] [Related]
6. Dyslipidemia in Children Treated with a BRAF Inhibitor for Low-Grade Gliomas: A New Side Effect?
Crocco M; Verrico A; Milanaccio C; Piccolo G; De Marco P; Gaggero G; Iurilli V; Di Profio S; Malerba F; Panciroli M; Giordano P; Calevo MG; Casalini E; Di Iorgi N; Garrè ML
Cancers (Basel); 2022 May; 14(11):. PubMed ID: 35681673
[TBL] [Abstract][Full Text] [Related]
7. Barriers to Immunotherapy in Ovarian Cancer: Metabolic, Genomic, and Immune Perturbations in the Tumour Microenvironment.
Johnson RL; Cummings M; Thangavelu A; Theophilou G; de Jong D; Orsi NM
Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944851
[TBL] [Abstract][Full Text] [Related]
8. Metabolic Plasticity in Melanoma Progression and Response to Oncogene Targeted Therapies.
Alkaraki A; McArthur GA; Sheppard KE; Smith LK
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830962
[TBL] [Abstract][Full Text] [Related]
9. Deregulated FASN Expression in BRAF Inhibitor-Resistant Melanoma Cells Unveils New Targets for Drug Combinations.
Stamatakos S; Beretta GL; Vergani E; Dugo M; Corno C; Corna E; Tinelli S; Frigerio S; Ciusani E; Rodolfo M; Perego P; Gatti L
Cancers (Basel); 2021 May; 13(9):. PubMed ID: 34068792
[TBL] [Abstract][Full Text] [Related]
10. Dual regulation of fatty acid synthase (FASN) expression by O-GlcNAc transferase (OGT) and mTOR pathway in proliferating liver cancer cells.
Raab S; Gadault A; Very N; Decourcelle A; Baldini S; Schulz C; Mortuaire M; Lemaire Q; Hardivillé S; Dehennaut V; El Yazidi-Belkoura I; Vercoutter-Edouart AS; Panasyuk G; Lefebvre T
Cell Mol Life Sci; 2021 Jul; 78(13):5397-5413. PubMed ID: 34046694
[TBL] [Abstract][Full Text] [Related]
11. The Cancer Cell Dissemination Machinery as an Immunosuppressive Niche: A New Obstacle Towards the Era of Cancer Immunotherapy.
Asiry S; Kim G; Filippou PS; Sanchez LR; Entenberg D; Marks DK; Oktay MH; Karagiannis GS
Front Immunol; 2021; 12():654877. PubMed ID: 33927723
[TBL] [Abstract][Full Text] [Related]
12. Lipid Metabolism and Lipidomics Applications in Cancer Research.
Pan M; Qin C; Han X
Adv Exp Med Biol; 2021; 1316():1-24. PubMed ID: 33740240
[TBL] [Abstract][Full Text] [Related]
13. Lipid metabolic Reprogramming: Role in Melanoma Progression and Therapeutic Perspectives.
Pellerin L; Carrié L; Dufau C; Nieto L; Ségui B; Levade T; Riond J; Andrieu-Abadie N
Cancers (Basel); 2020 Oct; 12(11):. PubMed ID: 33121001
[TBL] [Abstract][Full Text] [Related]
14. The Function and Mechanism of Lipid Molecules and Their Roles in The Diagnosis and Prognosis of Breast Cancer.
Guo R; Chen Y; Borgard H; Jijiwa M; Nasu M; He M; Deng Y
Molecules; 2020 Oct; 25(20):. PubMed ID: 33096860
[TBL] [Abstract][Full Text] [Related]
15. Obesity and the Impact on Cutaneous Melanoma: Friend or Foe?
Smith LK; Arabi S; Lelliott EJ; McArthur GA; Sheppard KE
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32549336
[TBL] [Abstract][Full Text] [Related]
16. Adipophilin expression in cutaneous malignant melanoma is associated with high proliferation and poor clinical prognosis.
Fujimoto M; Matsuzaki I; Nishitsuji K; Yamamoto Y; Murakami D; Yoshikawa T; Fukui A; Mori Y; Nishino M; Takahashi Y; Iwahashi Y; Warigaya K; Kojima F; Jinnin M; Murata SI
Lab Invest; 2020 May; 100(5):727-737. PubMed ID: 31857696
[TBL] [Abstract][Full Text] [Related]
17. Essentiality of fatty acid synthase in the 2D to anchorage-independent growth transition in transforming cells.
Bueno MJ; Jimenez-Renard V; Samino S; Capellades J; Junza A; López-Rodríguez ML; Garcia-Carceles J; Lopez-Fabuel I; Bolaños JP; Chandel NS; Yanes O; Colomer R; Quintela-Fandino M
Nat Commun; 2019 Nov; 10(1):5011. PubMed ID: 31676791
[TBL] [Abstract][Full Text] [Related]
18. Sustained SREBP-1-dependent lipogenesis as a key mediator of resistance to BRAF-targeted therapy.
Talebi A; Dehairs J; Rambow F; Rogiers A; Nittner D; Derua R; Vanderhoydonc F; Duarte JAG; Bosisio F; Van den Eynde K; Nys K; Pérez MV; Agostinis P; Waelkens E; Van den Oord J; Fendt SM; Marine JC; Swinnen JV
Nat Commun; 2018 Jun; 9(1):2500. PubMed ID: 29950559
[TBL] [Abstract][Full Text] [Related]
19. Metabolic strategies of melanoma cells: Mechanisms, interactions with the tumor microenvironment, and therapeutic implications.
Fischer GM; Vashisht Gopal YN; McQuade JL; Peng W; DeBerardinis RJ; Davies MA
Pigment Cell Melanoma Res; 2018 Jan; 31(1):11-30. PubMed ID: 29049843
[TBL] [Abstract][Full Text] [Related]
20. [Expression and clinical significance of DNAJB11 in epithelial ovarian cancer].
Guorong Y; Yunfeng FU; Yanli LI; Caiyun Z; Weiguo LV
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2017 Mar; 46(2):173-178. PubMed ID: 28752709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
